Nucleic acids encoding TGF-beta inhibitors and IL-12 and uses thereof

JP2025536947A5Pending Publication Date: 2026-10-16KALIVIR IMMUNOTHERAPEUTICS INC
0 Cites 0 Cited by

Patent Information

Application Number
JP2025522578
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-06-08
Filing Date
2023-10-18
Publication Date
2026-10-16

AI Technical Summary

Technical Problem

Cancer cells overexpress TGF-beta, which evades the host immune response, necessitating compositions and methods to target and modulate TGF-beta activity in the microenvironment.

Method used

A composition comprising nucleic acids encoding IL-12 and TGF-beta inhibitors, delivered via a vaccinia-based vector, enhances anti-tumor immune responses by blocking TGF-beta signaling and promoting IL-12 expression, utilizing CXCR3 ligand-rich tumors for systemic delivery.

Benefits of technology

The combination of IL-12 and TGF-beta inhibitors in the tumor microenvironment improves therapeutic efficacy by reducing immune suppression and enhancing antitumor responses, leading to tumor growth inhibition and increased survival.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The present disclosure provides nucleic acids encoding transforming growth factor inhibitors and IL-12. Further, nucleic acids encoding the chemokine receptor CXCR3 are provided herein. Additionally, oncolytic viruses comprising the nucleic acids described herein are described herein. The compositions described herein are further described for use in the treatment of cancer. Described herein is a composition comprising a vector, the vector comprising an exogenous nucleic acid comprising a sequence encoding a cytokine or a functional variant thereof, an exogenous nucleic acid comprising a sequence encoding a chemokine receptor or a functional variant thereof, and a first promoter region upstream of the sequence encoding the chemokine receptor, causing expression of the chemokine receptor before expression of the cytokine.
Need to check novelty before this filing date? Find Prior Art